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Abstract
Purpose During ovarian follicle growth, local cellular inter-
actions are essential for oocyte quality acquisition and suc-
cessful fertilization. While cumulus cells (CCs) nurture oo-
cytes, they also deliver oocyte-secreted factors (OSFs) that
activate receptors on CCs. We hypothesized that disturbance
of those interactions contributes to age-related lower repro-
ductive success in women submitted to assisted reproductive
technology treatments.
Methods Women aged 27–48, without recognized personal
reproductive disorder, were enrolled in the study and divided
in <35- and ≥35-year-old groups. CCs collected upon follicle
aspiration were processed for immunocytochemistry and
RNA extraction. The expression patterns of OSF receptors
BMPR2, ALK 4, ALK5, and activin receptor-like kinase
(ALK6) were studied.
Results Independently of age, receptors were found mostly in
the cell periphery. The quantitative assay revealed that in older
women, BMPR2, ALK 4, and ALK6 were all significantly
decreased, whereas ALK5 was slightly increased.
Conclusions Female age imparts an effect on the expression
of OSF receptors in CCs. The findings indicate that reproduc-
tive aging affects the local regulation of signaling pathways
mediated by BMPR2, ALK6, and ALK4 receptor activation,
suggesting their joint involvement.
Keywords Aging . Cumulus cells . Female infertility . Gene
expression . Growth factors
Introduction
In the course of the ovarian follicle development, oocytes
progress tometaphase II stage and acquire the biological prop-
erties to be fertilized [1]. They are surrounded by a cellular and
liquid environment, composed of differentiated, granulosa-
derived cumulus oophorus cells (CCs) and the follicular fluid
(FF) compartment. The diversity of FF biomolecules and the
peculiarities of the intercellular contacts make this
environment unique.
The FF is a rich solution of peptides and steroids
derived from the oocyte, the CCs, the granulosa cells,
and the circulation [2]. In contrast to FF, which may
function as a pool of compounds, CCs interact perma-
nently with the oocyte and acquire new structural and
functional properties, distinct from their granulosa cell
ancestors. The mechanism behind this differentiation is
likely a morphogen gradient, by which similar cells are
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directed into different structural and functional destina-
tions as a consequence of the concentration of specific
molecular signals [3]. In the follicle, while mural cells
remain actively steroidogenic, human CCs form cyto-
plasmic extensions that penetrate the zona pellucida
and establish intimate contacts with the oocyte mem-
brane by specialized features as gap junctions [4].
Before fertilization, this morpho-functional organization
will enable a bidirectional communication between the
oocyte and granulosa cells, crucial for the next develop-
mental processes such as embryogenesis [5].
Oocyte-secreted factors (OSFs) have growth factor
properties when acting on granulosa cells. They include
members of the transforming growth factor beta (TGFB)
superfamily of which the growth differentiation factor 9,
GDF9, and the structurally related bone morphogenetic
protein 15, BMP15, are very important for a variety of
species [6]. In the Gdf9 knockout mice, ovaries maintain
the normal structure but follicles do not evolve beyond
the primary follicle stage [7] and oocytes evidence secre-
tory disturbances [8]. Bmp15 knockout female mice also
have reproductive alterations, albeit minor. Their ovulato-
ry response to pharmacological stimulation, litter size, and
litter frequency is reduced; moreover, the number of CCs
enveloping oocytes is also smaller, suggesting that, in
contrast to GDF9, the intervention of BMP15 occurs later
in mouse folliculogenesis [9].
Considerable evidence on the importance of OSFs in fer-
tility was gathered over the last years [5–16]; however, less
consistent is the structure and dynamics of their receptors,
mainly due to the lack of in vivo studies on account of the
lethality of some genetic modifications [13].
OSFs form dimers that signal through membrane receptors.
In vitro studies have identified receptor arrangements capable
of interacting with GDF9:BMP15 heterodimers, whose bio-
logical activity is stronger, compared to OSFs homodimers
[14, 15].
Receptors are composed of two types of serine/threonine
kinases, members of the TGFB receptor superfamily, that in-
clude type 1 (ALK 1–7) and type 2 (BMPR2 and TGFBR2)
receptors [6]. It has been considered that they assemble as
different tetramers that, when interacting with the OSF hetero-
dimers, are composed of one type 2 (BMPR2) homodimer, an
ALK4/5/7 type 1 receptor (likely ALK4), and an ALK6 type 1
co-receptor, apparently involved in receptor organization sta-
bility [14].
Upon ligand interaction, type 2 receptor transphosphorylates
type 1, which promotes the activation of the cytoplasmic SMAD
protein cascade [6, 12], in which the proteins translocate into the
nucleus to function as transcription factors [11]. Despite their
structural similarities, BMP15 and GDF9 activate, in a species-
relatedway, different downstream signaling cascades, respective-
ly SMAD 1/5/8 and 2/3 [12–15].
The peculiar structural organization of CCs around the oo-
cyte favors their continuous interaction. In fact, CCs provide
nutrients to the oocytes [16, 17], protect them from oxidative
stress [18, 19], and endow the oocyte with additional condi-
tions for fertilization [20]. To accomplish those tasks, CCs
actively express a large number of genes involved in a varied
number of cell processes [21, 22], whose study may be an
important tool in the evaluation of oocyte quality [23]. CCs
are also capable of expressing OSFs, and apparently their
transcription is inhibited by women’s physiological status in-
cluding overweight or aging [24].
The cumulus cells/oocyte crosstalk is likely to be disturbed
in some fertility disorders and in the course of natural repro-
ductive aging, a major risk factor for female fertility [25].
Structural, unbiased ovarian studies evidenced age-related
decrement in non-growing follicles [26], supporting previous
epidemiological data showing age-related decreased pregnan-
cy rates in groups not using contraception [27] and women
submitting to artificial insemination [28]. Furthermore, in
assisted reproductive technology (ART) procedures,
employing previously selected oocytes, the trends were not
different. In European countries, the overall pregnancy rate
following intracytoplasmic sperm injection (ICSI) was
35.2% in women aged ≤34 years and decreased to 14.0% at
≥40 years; in in vitro fertilization (IVF), the rates were 35.4
and 14.7% at the same age ranges [29]. Other similar trends
were found in the USA [30], Australia, and New Zealand [31].
There is thus compelling evidence for the age-related re-
duction in women’s fertility. Beyond follicle loss, additional
focus has been put on the decrement in oocyte quality conse-
quent to enhanced meiotic non-disjunction, oocyte damage,
and changes in the quality of the surrounding cells [32], fur-
ther emphasizing the importance of oocyte environment. As
CCs are part of such environment, we hypothesized that aging
imparts functional disturbance on them that jeopardize their
interaction with the oocyte. To address it, we verified the
expression of main OSF receptors in human cumulus
oophorus cells along reproductive aging.
Material and methods
Women who participated in this study were observed at
Centro de Estudo e Tratamento da Infertilidade (CETI),
Porto, Portugal, during the assessment of fertility disorders.
Diagnoses were established by experts on Reproductive
Medicine, and all decisions for invasive procedures and the
choice of ARTand specific technique to employ (IVF or ICSI)
were based on clinical criteria.
The proposed research work was assessed by the Bioethics
Unit, Biolaw and Economy of Health of the Department of
Social Sciences and Health—Faculty of Medicine, University
of Porto, which in turn issued a positive opinion to this study
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as it was approved without any ethical constraints since the
principles and established protocol were always respected.
Procedures were performed after patient informed consent,
and under no circumstances, CC harvesting and study com-
promised the ordinary course of ART procedures.
Including criteria were male factor, previous tubal ligation,
and infertility of unknown cause. Women with endometriosis,
suspected past pelvic infection, polycystic ovary syndrome
(PCOS), and other identifiable anovulatory conditions were
excluded. Women’s age was assigned to two groups: younger
(<35 years) and older (≥35 years), assuming that oocyte qual-
ity significantly decreases from that age onwards. The demo-
graphic and baseline characteristics of these women and their
treatments are presented in Table 1.
Ovarian stimulation protocols
A flexible antagonist protocol with recombinant, urinary, or
both types of gonadotropin was employed. Gonadotropin ad-
ministration started on day 2 of the menstrual cycle, and the
GnRH antagonist was administered upon ultrasound identifi-
cation of one follicle ≥14 mm diameter or more than 1 follicle
exceeding 12 mm. When three follicles reached ≥17 mm in
diameter and women had completed approximately 9 days of
ovarian stimulation, 10,000 I.U. of human chorionic gonado-
tropin (HCG) was administered. Dosage was adjusted accord-
ing to age and ovarian response. Ultrasound-guided
transvaginal follicular puncture was performed in the next
34–36 h for follicle aspiration and oocyte-CC retrieval.
Collection of cumulus cells
After oocyte pickup under stereomicroscope observation, the
cumulus-oocyte complexes (COCs) were washed in Sperm
Preparation Medium (Origio, Denmark) and classified mor-
phologically, employing previously described criteria [33,
34]. Each complex was analyzed individually.
CCs from COCs exhibiting apparently mature, fully ex-
panded, and well defined corona radiata [34] were mechani-
cally removed and placed in an anonymized sterile Eppendorf
tube (Eppendorf International, Germany). They were washed
with 1 mL of sterile DPBS 1× and centrifuged at 235×g for
6 min at 4 °C. Upon removal of the supernatant, a part of the
sample was put in a cryotube and frozen in liquid nitrogen
until processing for qPCR. Another part was digested with
hyaluronidase (SynVitro® Hyadase; Origio, Denmark) for
30 s under continuous pipetting. Cells in suspension were then
washed with 1 mL of sterile DPBS 1× and centrifuged as
above. After supernatant removal, CCs were smeared on clean
poly-L-lysine coated slides for immunocytochemistry (ICC)
analysis.
Extraction of RNA and cDNA production
In previously frozen CC samples, total RNAwas extracted by
RNeasy® Plus Mini Kit (Qiagen, Canada) according to the
manufacturer’s instructions, which included genomic DNA
prior to removal through a gDNA eliminator column provid-
ed. RNA quantification was performed by spectrophotometric
reading (NanoDrop ND-1000 ™ software 13.3.0, NanoDrop
Technologies, USA) at 260 nm, and the degree of purity was
estimated based on the ratio of absorbances at 260 and
280 nm, with reference values from 1.9 to 2.1. RNA was
stored at −80 °C until subsequent tests were performed.
Complementary DNA (cDNA) was produced from a 50 ng
RNA sample through the qScript™ cDNA Synthesis Kit
(Quanta BioSciences, USA), following the manufacturer’s
recommendations. As internal control, a similar reaction, but
lacking reverse transcriptase, was made in parallel. A total of
56 RNA samples were successfully converted to 56 cDNA,
labeled and stored at −20 °C until further analysis.
Real-time quantitative PCR
The designed sequences of each primer pair (Table 2) were
analyzed using the software Beacon Designer™ (PREMIER
Biosoft International, USA) to assess their applicability in
qPCR.





Number of patients (n) 36 20
Age (years) 31.7 ± 2.3 38.7 ± 3.4
Total FSH (IU) ministered
during ovarian stimulation
1426.2 ± 661.5 2082.5 ± 1149.3
Total FSH days 8 ± 2.3 9 ± 1.2
Number of retrieved oocytes 5 ± 2.9 4 ± 2.1
Data are the mean ± SD of the two groups of women in which CCs
(ntotal = 56) were analyzed by qPCR
Table 2 Human receptor gene sequences of forward (F) and reverse
(R) cDNA primers and amplicon size
Target gene Primer sequence (5′ → 3′) Amplicon size
(bp)
BMPR2 F: TCTTTGCCCTCCTGATTCTTG 136
R: CACATAGCCGTTCTTGATTCTG
ALK6/BMPR1B F: CATTCCTCATCAAAGAAGATC 459
R: TCCTCTGTGGTGAAGAACAC
ALK5/TGFBR1 F: AAAACTTGCTCTGTCCACGGC 826
R: TGTCCTGGGAAAGAAGCGTTC
ALK4/ACVR1B F: TGTGATCAGAAGCTGCGTCC 96
R: GGCATACCAACACTCTCGCA
GAPDH F: GGTGAAGGTCGGAGTCAACG 497
R: CAAAGTTGTCATGGATGACC
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Other conditions for qPCR were optimized, including the
program to be used, summarized in Table 3.
All qPCR reactions were performed in duplicate, including
a negative control with all the PCR components except first-
strand cDNA, in a final volume of 20 μL using 10 μL of iQ™
SYBR®Green Supermix (Bio-Rad, USA).GAPDHwas cho-
sen as housekeeping/reference gene.
Upon qPCR run, Ct values for each amplification reaction
were determined using the Bio-Rad IQ5 Optical System
Software (Bio-Rad, USA); to estimate the absolute value of
expression of the gene of interest, we employed the delta Ct
method (ΔCt), with the following formula: 2(Ct(reference
gene)−CT(target gene)). This approach uses the value of expression
of a reference gene in place of a mass unit, in order to stan-
dardize the analysis. The choice of this method was mainly
due to the low amount of sample.
Immunocytochemistry
CC smears on poly-L-lysine-coated slides were incubated with
the membrane glycoprotein marker concanavalin A (Con-A),
when applicable, and fixed by brief immersion in formalde-
hyde in PBS 0.1 M, pH 7.4. Cells were then permeabilized
with 1% Triton X-100, blocked with 10% normal goat serum
(NGS) in PBS 0.1 M, pH 7.4 (for detection of anti-hBMPR1B
and anti-hTGF beta R1), and 5% bovine serum albumin
(BSA) in PBS 0.1 M, pH 7.4 (for detection of anti-BMPR2).
Incubation with primary antibodies, goat anti-hBMPR2 (1:20;
AF811, R&D Systems®, USA), rabbit anti-hTGF beta RI
(1:50; V-22, Santa Cruz Biotechnology, Inc., USA), and
mouse anti-h/mBMPR1B (1:20; MAB505, R&D Systems®,
USA) was performed overnight. Cells were thoroughly
washed and then incubated with fluorescent secondary probes
diluted in PBS 0.1% Tween 20 (anti-hBMPR2 reaction) or in
blockage solution (anti-hBMPR1B and anti-hTGF beta RI
reactions) for 1 h at room temperature, followed by binding
induction with 488 streptavidin or appropriate Alexa fluoro-
chrome (Alexa Fluor®, Invitrogen, UK). Cells were washed
again in PBS-Tween20 and briefly exposed to DAPI, no longer
than 2 min. For the negative controls, the ICC procedure was
the same as that mentioned above, without adding the primary
antibodies. Slides were immediately examined with the
ApoTome fluorescence microscope (Zeiss, Germany), and
the images were captured with the digital imaging acquisition
equipment and analyzed by the software AxioVision LE
(Zeiss, Germany).
Statistical analysis
Assuming to work with independent samples, without a nor-
mal distribution, the Mann-Whitney non-parametric test was
used to compare the median values of transcript expression
levels, between the two groups of samples. Data analysis was
conducted with IBM SPSS Statistics 20.0 (IBM Corporation,
USA); p < 0.05 was considered as statistically significant. To
check whether our results were due to a lack of statistical
power, post hoc power analyses were conducted using
G*Power 3.0.10 (Franz Faul, Universität Kiel, Germany) with
power (1 − β) set at 0.80 and α = 0.05, one-tailed.
Results
TGFB receptor mRNA expression levels
Results of receptor mRNA expression levels in the studied
groups are depicted in Fig. 1.
Both BMPR2 and ALK6 messenger RNA (mRNA) was
significantly decreased in samples from older women com-
pared to younger women, with significance levels of
p = 0.002 and p = 0.013, respectively. Post hoc power analysis
detected differences between the two independent groups
(p < 0.05), 0.92 for BMPR2 and 0.84 for ALK6. As for
ALK4, a significantly decreased mRNA was quantified in
older women (p = 0.022), however, with weaker power
(0.49). Regarding ALK5 mRNA, it registered an increase in
samples from older women without statistical significance
(p = 0.067). In order to have a difference to be detected
(95% chance) as significant at the 5% level (α = 0.05), for
ALK4 and ALK5, a total of 74 and 397,260 samples, respec-
tively, would be required. Due to the low amount of starting
material in the CC samples, TGFB receptor mRNA expres-
sion detection may have conditioned the deviations noted.
ICC detection of TGFB receptors in dissociated CCs
In unstained smears, hyaluronidase-dissociated CCs exhibited
irregular shape and variable size and were surrounded by
rough deposits, likely due to dried albumin and salts. Simple
staining was rendered difficult. In contrast, hyaluronidase-
dissociated cells subsequently washed in PBS allowed stain-
ing improvement and the ICC study. Cells appeared more
frequently as single cells, sometimes as pairs and occasionally
Table 3 Programs used in qPCR
GAPDH
ALK4/ALK6/BMPR2 ALK5
Cycle phase T (°C) Time (s) T (°C) Time (s)
Denaturation 94 600 94 600
94 45 40 cycles 94 45 40 cycles
Annealing 58 30 61 60
Extension 72 60 72 60
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in larger groups, exhibiting a round shape and a conspicuous
nucleus (Fig. 2).
The ICC study evidenced the preferential cell surface lo-
calization of type 1 receptors (as ALK5 and ALK6) although
ALK6 showed considerable labeling intensity in the cyto-
plasm (Fig. 2a, b). Both type I receptors co-localized with
BMPR2 as depicted in Fig. 2c, d. Age did not result in altered
receptor localization (data not shown).
Discussion
The reciprocal and continuous paracrine communication at the
cumulus cell-oocyte complex interaction [35, 36] has been
emphasized as necessary for successful follicular growth, cu-
mulus cell differentiation, ovulation, and fecundity (see [12]
for a comprehensive review).
GDF9 and BMP15 are important oocyte communication
signals that are expressed early in primordial follicles and
attain stronger intensity from the primary/secondary follicle
stage onwards. They were identified in a variety of mamma-
lian species, including humans and other essentially mono-
ovulatory mammals as sheep [37], goat [38], and bovine
[39]. In humans, GDF9 and BMP15 expression was observed
mainly in the oocytes at various ages as the fetal period, pre-
menarche, and adulthood [40–43]. Upon controlled ovarian
stimulation (COS), as is the condition of the present investi-
gation, oocyte GDF9 expression increases until ovulation,
when higher levels of expression are attained [44, 45]; in
contrast, BMP15 is expressed later in the cycle, when primary
follicles are well established [41], and the labeling intensity is
smaller compared to GDF9 [45].
OSFs have important effects on the cells surrounding the
human oocyte. In ex vivo studies, GDF9 promoted primordial
follicle growth, differentiation, and viability [46], in agree-
ment with the Gdf9−/− mice’ lack of folliculogenesis progress
[7]. In contrast, Bmp15 inactivation in mice did not result in
important developmental or structural changes, even upon
stimulation, indicating that BMP15 effects on folliculogenesis
are minor and established later [11].
However, mouse model information may not extend to
other mammalian species as mono-ovulatory mammals,
where absent functional BMP15 resembles mouse GDF9 in-
activation. In fact, women with BMP15mutations exhibit pre-
mature ovarian failure [47, 48], similarly to some homozy-
gous BMP15 sheep mutants, whose folliculogenesis is
Fig. 1 TGFB receptor transcript (ΔCt) expression according to age
group (<35 and ≥35 years). For each receptor, a box-and-whisker plot is
presented, illustrating the median, 1st and 3rd quartiles, and minimum
and maximum values (lower and upper bars). Differences are expressed
as **p < 0.01, *p < 0.05, or NS (non-significant)
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blocked [49]. In addition, oocyte BMP15 expression in mice
remains low until close to ovulation [50], whereas in human
[41] and sheep [37] oocytes, the expression is already evident
at the primary follicle stage. This point adds further to specific
effects of BMP15 in mono-ovulatory mammals, compared to
non-mono-ovulatory mammals, and emphasizes an interven-
tion in follicle growth and differentiation, despite the knowl-
edge gap on its modulatory role in humans [51].
In the present investigation, we addressed GDF9 and
BMP15 receptors in the human granulosa-derived CCs, where
they have been localized [6, 10, 14], including upon COS [21,
24]. These members of the TGFB receptor superfamily are
synthesized in the rough endoplasmic reticulum, transported
to the Golgi complex as proproteins, and then routed to the
cell membrane [52]. The cytoplasmic and cell surface immu-
nocytochemical labeling of CCs here described generally cor-
respond to those different cell locations. However, receptor
mRNA expression was different when young and aged
women’s cells were compared. In fact, there was reduction
in mRNA amount of all three BMPR2, ALK4, and ALK6
receptors, accompanying the reduced reproductive fitness that
occurs in aged women. Such joint reduction in expression
adds importance to previous observations favoring ALK4 as
a major type 1 component of the receptor complex that re-
sponds strongly to the GDF9:BMP15 heterodimer, by activat-
ing SMADs in vivo and in vitro [14, 15, 53]. In this point, it
Fig. 2 Representative
immunocytochemical labeling of
TGFB receptors in human
cumulus oophorus cells. a ALK5
(green) and the membrane marker
Con-A (red) are detected and co-
localize at the periphery of the
cells (yellow). b ALK6 (green)
and Con-A (red) are detected and
co-localize (yellow) at the
periphery of the cells too; note
that ALK6 also exhibits a
considerable intracellular
labeling. c ALK5 and BMPR2
detection in human CCs; ALK5
(red) and BMPR2 (green) co-
localize especially on cell
periphery (yellow). d ALK6 (red)
and BMPR2 (green) were
detected and co-localize
predominantly in the cytoplasm
(yellow). e Negative controls,
without the corresponding
primary antibodies. a–e Nuclei
were counterstained with DAPI
(blue). Bars = 10 μm
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emphasizes the value of the GDF9 and BMP15 interaction in
COC maturation.
In contrast, to the three receptors, the slight increase in
ALK5 indicates that it has a different, or secondary, involve-
ment, eventually non-reproductive, in human cumulus cells.
In fact, SMAD 2/3 cascade activation upon stimulation with
GDF9/BMP15 heterodimers is still evidenced in Alk5 cKO
mice [13].
Due to scarcity of the data on human OSF receptor regula-
tion, the interpretation of the changes here reported benefits
from observations in other mono-ovulatory species such as
some sheep strains that carry mutations on the BMP15 coding
sequence of regulatory elements and ALK6 itself [54]. In the
Woodland variety of sheep, there is a putative X chromosome
mutation, FecX2W, that modulates BMP15 expression. When
compared to wild-type subjects, heterozygous carriers show
reduced expression of oocyte BMP15, unchanged GDF9 ex-
pression, and reduced expression of BMPR2 and ALK6 re-
ceptors on granulosa cells from antral follicles [55]. It is thus
conceivable that the age-related reduced level of expression of
BMPR2/ALK6/ALK4 receptors that we observed in human
CCs relates to reduced secretion of one or both OSFs and their
reduced heterodimerization. As in the same variety of mutants
the granulosa cell ALK5 receptor was slightly increased, the
findings in Woodland sheep parallel those we found in aged
women.
The resemblance of receptor expression variations compels
to an additional observation. It is known that homozygous
Woodland ewes are usually sterile, exhibit streak ovaries,
and evidence folliculogenesis block at early stages, whereas
their heterozygote counterparts have higher ovulatory rates
and are more prolific [55]. In women, mutations in BMP15
and GDF9 also result in premature ovarian failure and streak
ovaries [47, 48, 51, 56, 57], elevated serum FSH [56] and,
occasionally, dizygotic twining [58]. Interestingly, FSH eleva-
tion was noticed in Booroola sheep variety, which has a mu-
tation in the ALK6 receptor [59]; moreover, enhanced follic-
ular sensitivity to FSH, in the setting of reduced bioactive
BMP15 level, was the proposed mechanism [54] for the pro-
lific heterozygous Woodland sheep. In fact, these ewes exhib-
ited a larger number of antral follicles, although the size of
follicles and oocytes was smaller [55], indicating that from the
original cohort, more oocytes had been recruited to ovulate. It
is noteworthy that the slight elevation of blood FSH observed
later in women’s reproductive life, resulting in the occasional
ovulation of two smaller follicles, was the proposed mecha-
nism for the recognized enhanced incidence of dizygotic twin-
ing observed at that age [60]. In those healthy older women,
reduction of BMP15 and GDF9 secretion was also suggested
as the plausible cause [61].
In the clinical setting, when older and younger women are
compared regarding infertility causes, an increase in tubal ob-
struction and infertility of unknown cause is noticed [62].
While the first condition associates to the effects of external
causes, as infections or endometriosis, the second condition is
likely to result from intrinsic, age-related, functional distur-
bances at the COC. In the current study, we found a decrement
in CC receptors, notably the type 1 ALK4 and ALK6 recep-
tors that assemble for GDF9/BMP15 heterodimer interaction.
One might speculate that age-related reduced secretion of
OSFs is a fundamental event that hinders heterodimerization,
prevents CCs activation, and leads to COC development dis-
turbances and reduced fertility.
This study also shows that CC assessment is able to pro-
vide relevant information on COC functioning. Similarly to
other views [23, 63], we are convinced that they are a mirror of
oocyte quality and their study will help to fine tune the diag-
nosis and ameliorate the prognosis for fertility disorders.
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